CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Therapeutics Companies in Canada Top Therapeutics Companies in Canada - 2024 Top Therapeutics Companies in Canada - 2023 Top Therapeutics Solutions Companies in Canada - 2023

Life Sciences Review

Therapeutics

Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

Rachel Legmann

PhD, Senior Director of Technology, Gene Therapy

Repligen Corp

Leveraging Technological Advancements for Developing Innovative Therapeutics

Marc de Garidel

CEO and Interim Chairman

Abivax [EPA: ABVX]

Featured Issue
#

Potential Cannabidiol (CBD) Treatment for Anxiety Disorders (ADS): Work In Progress

Ivan A. Salazar, Plant Packaging & Sanitation Manager Organigram Inc
#

Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker Zai Lab
#

Worldwide Patients Access to Life-Changing Therapies

Kinga Bercsenyi, PhD, European Lead for Precision Medicine & Biomarker Solutions Cerba Research
#

Setting Up Organizations for Long-Term Follow-Up Studies

Nelly Marmy Conus, DCT Manager, Decentralized Solutions Syneos Health
The Rise in Outsourcing Clinical Trials

The Rise in Outsourcing Clinical Trials

Erika Vento-Gaudens, Director, Global Clinical Trial Operations

Guardant Health

Novel Nanotechnology in CAR-T Therapy Targeting Solid Tumors

Novel Nanotechnology in CAR-T Therapy Targeting Solid Tumors

Hong Ma, MD, Sr Vice President of Clinical Development

CARsgen Therapeutics

#

Advanced Tissue Technologies Maximize Flexibility in Regenerative Medicine

Thomas Gilbert, Ph. D., Vice President, Research & Development

Integra Lifesciences

News

Evidence before Expansion in Stem Cell Therapy

Molecular Pathology Built Around Clinical Context

Stem Cell Therapy Treatments: Advancing Regenerative Medicine through Cellular Innovation

CMMS and EAM Software: Strengthening Asset Performance across Life Sciences

Making Cell Therapy Accessible to All Patients

Making Cell Therapy Accessible to All Patients

Nuala Trainor, Director of Innovation

Lonza [SWX: LONN]

Artificial Intelligence and the Healthcare Industry

Artificial Intelligence and the Healthcare Industry

Kelly H. Zou, PhD, PStat®, FASA, Head of Global Medical Analytics and Real World Evidence, Viatris

The Next Technological Advancement in Resin Development

The Next Technological Advancement in Resin Development

Sofie Stille, Vice President of Technology,

Cytiva

The Untapped Potential of Medical Affairs in Generics, Value added medicines and Hybrid pharmaceuticals

The Untapped Potential of Medical Affairs in Generics, Value added medicines and Hybrid pharmaceuticals

Andreas Søderman, Head of Medical Affairs

Orifarm

Driving Success in the Dynamic Pharma Industry

Driving Success in the Dynamic Pharma Industry

SANOBAR SYED, Associate Director, BeiGene

Leveraging Technological Advancements for Developing Innovative Therapeutics

Leveraging Technological Advancements for Developing Innovative Therapeutics

Marc de Garidel, CEO and Interim Chairman

Abivax [EPA: ABVX]

Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy

Repligen Corp

Ebovir: Facilitating Advanced Antiviral Therapy Development

Facilitating Advanced Antiviral Therapy Development

Zhenlong Liu, PhD, Co-founder

Loading...
#

Engineering Bacteriophages for Refined Therapy

Dr. Steven Theriault, CEO & CSO

#

Enhancing Drug Delivery with Next-Generation Platform Technology

Mr. Sébastien Plouffe, Chief Executive Officer,

#

Forerunners in Novel DNA-damage Response (DDR) Technologies

Jeffrey Bacha, Executive Chairman; Mads Daugaard, President, and Chief Scientific Officer; David Hyman, Chief Financial Officer

#

Transforming Pharmaceutical Marketing in Canada

Tamara Seales, President

Empowering Breeders with Effective  Antibiotic Alternatives

Empowering Breeders with Effective Antibiotic Alternatives

Rodrigue DUBAR, CEO , Simon Labrie, CSO

A Stealth Biotech with a Global Vision

A Stealth Biotech with a Global Vision

Sachdev Sidhu, CSO, EPOK Therapeutics

Evolution of Viral Vector Analytics for Gene Therapy

Evolution of Viral Vector Analytics for Gene Therapy

Rachel Legmann, PhD Senior director of technology, gene therapy, Repligen Corp.

Creating Human-Centered AI Ecosystems in Healthcare

Creating Human-Centered AI Ecosystems in Healthcare

Dr. Justin Grant, Vice President of Research and Innovation, Humber River Health

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://therapeutics-canada.lifesciencesreview.com